Growth Metrics

Evolent Health (EVH) Depreciation & Amortization - Total (2016 - 2026)

Evolent Health has reported Depreciation & Amortization - Total over the past 11 years, most recently at $6.3 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization - Total fell 14.86% year-over-year to $6.3 million; the TTM value through Dec 2025 reached $26.3 million, down 13.2%, while the annual FY2025 figure was $26.3 million, 13.2% down from the prior year.
  • Depreciation & Amortization - Total for Q4 2025 was $6.3 million at Evolent Health, roughly flat from $6.3 million in the prior quarter.
  • Over five years, Depreciation & Amortization - Total peaked at $8.9 million in Q4 2022 and troughed at $6.3 million in Q3 2025.
  • A 5-year average of $7.6 million and a median of $7.6 million in 2021 define the central range for Depreciation & Amortization - Total.
  • Biggest five-year swings in Depreciation & Amortization - Total: increased 14.71% in 2021 and later dropped 18.99% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $7.8 million in 2021, then rose by 14.1% to $8.9 million in 2022, then fell by 14.61% to $7.6 million in 2023, then fell by 2.63% to $7.4 million in 2024, then dropped by 14.86% to $6.3 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for EVH at $6.3 million in Q4 2025, $6.3 million in Q3 2025, and $6.4 million in Q2 2025.